Concepedia

Publication | Open Access

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias

204

Citations

27

References

2011

Year

Abstract

This crossover study provides Class II evidence that 4AP decreases attack frequency and improves the patient-reported quality of life in patients with episodic ataxia and related familial ataxias.

References

YearCitations

Page 1